Drug intelligence / Profile preview

allogeneic platelet lysate

Development stage
Phase 2
Lead developer
Mill Creek Life Sciences
Administration
Topical, Local Injection, Intracranial, Intrathecal, Intranasal
01

Overview

Allogeneic platelet lysate is an acellular biological product derived from pooled human donor platelets. It is rich in growth factors (such as PDGF-AA/AB/BB, TGF-β1, IGF1, BDNF, EGF, VEGF, HGF), cytokines and chemokines that are released upon lysis of platelets. The product also contains plasma proteins (albumin and protease inhibitors), immunoglobulins (G/A/M), minerals (sodium, potassium, magnesium), vitamins and glucose[1]. Allogeneic platelet lysate is used primarily as a supplement for cell culture media in regenerative medicine and cell therapy manufacturing to promote proliferation of various cell types including mesenchymal stem cells and endothelial cells[5]. It has also been investigated for direct therapeutic use in tissue regeneration and neuroprotection due to its ability to modulate inflammation and support wound healing processes[4][1]. Mechanistically it acts by delivering a concentrated mix of trophic factors that stimulate cellular proliferation/survival pathways such as PI3K/AKT signaling[4].

Other names
human platelet lysateHPLAlloPLallogenic platelet lysate

Beyond the preview

Go deeper on allogeneic platelet lysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic platelet lysate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call